Intra-gastric balloon for weight loss: Preliminary analysis of efficacy & tolerability

Pakistan Journal of Medical and Health Sciences

Volumn 8, Issue 1, 2014, Pages 224-229

  Zafar, Shamail ^a   Haque, Israr Ul ^a   Farooq, Mehrin ^a   Bashir, Hira ^a   Khan, Gulsena Masood ^a   Chaudry, Nusrat Ullah ^a  

^a GHURKI TRUST TEACHING HOSPITAL   (Pakistan)

Author keywords

Body mass index; Intra gastric balloon; Obesity; Weight loss

Indexed keywords

ANTIEMETIC AGENT; PROPOFOL; PROTON PUMP INHIBITOR; SODIUM CHLORIDE; SPASMOLYTIC AGENT;

ABDOMINAL PAIN; ADULT; ARTICLE; BODY MASS; BURN; CLINICAL ARTICLE; CONSULTATION; DIET; DIETITIAN; EPIGASTRIC DISCOMFORT; EPIGASTRIC PAIN; ESOPHAGITIS; EXERCISE; FEMALE; GASTRIC BALLOON; HOSPITAL PATIENT; HUMAN; MALE; MORBID OBESITY; MORBIDITY; NAUSEA; PEPTIC ULCER; PERFORATION; STOMACH; STOMACH EROSION; VOMITING; WEIGHT REDUCTION;

EID: 84899838677     PISSN: 19967195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity, Geneva, 3-5 June 1997. Report no.: WHO/NUT/NCD/98.1 (1997).
2. Mathus-Vliegen EM, Tytgat GN, et al. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by 1-year balloon free follow-up. Gastrointest Endosc.2005: 61; 19-27. (Pubitemid 40169806)
3. National institute of Clinical excellence. Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children. National Institute of Clinical Excellence, www.nice.org.uk/CG43 (2006).
4. Pasquali, R. et al. Mechanisms of action of the intragastric balloon in obesity: effects on hunger and satiety. Appetite 1990: 15; 3-11.
5. Busetto L, Mirabelli D, Petroni ML et al. Comparative long-term mortality after laparoscopic adjustable gastric banding versus nonsurgical controls. Surg Obes Relat Dis.2007; 3(5):496-502 (Pubitemid 47454437)
6. Carvalho GL, Barros CB, Okazaki M, et al. An improved balloon procedure using a new balloon: Preliminary analysis of safety and efficiency. Obes Surg.2009;19: 237-42.
7. Dastis NS. et al. Intragastric balloon for weight loss: results in 100 individuals followed for at least 2.5 years. Endoscopy 2009: 41(7); 608-11
8. Genco A, Cipriano M, Bacci V, et al. Bioenterics Intragastric Balloon (BIB®): a short-term, double-blind, randomized, controlled, crossover study on weight reduction in morbidly obese patients. Int J Obes. 2006;30:129-33. (Pubitemid 41790788)
9. Herve J, Wahlen CH, Schaeken A, et al. What becomes of patients one year after the intragastric balloon has been removed? Obes Surg. 2005;15:864-70. (Pubitemid 40904880)
10. Evans JD, Scott MH. Intragastric balloon in the treatment of patients with morbid obesity. Br J Surg. 2001;88:1245-8. (Pubitemid 34015611)
11. Mathus-Vliegen EM. News and Views. Intragastric balloons-A bubble to combat the obesity bubble? Nature Reviews/Gastroenterology and Hepatology 2010;7:7-8
12. L. de Castro et al. Safety, efficacy and tolerance of two types of intragastric balloons placed in obese subjects. A double blinded comparative study. Gut 2009; 58 (Suppl II) A119
13. Mion F, Gincul R, Roman S, et al. Tolerance and Efficacy of an Air-filled Balloon inNon-morbidly Obese Patients: Results of a Prospective Multicenter Study. Obesity Surgery 2007; 17:764-769. (Pubitemid 46999041)
14. Forestieri P, De Palama GD, Formato A, et al. Heliosphere Bag in the treatment of severe obesity: Preliminary Exerience. Obes Surg 2007;16:635-637. (Pubitemid 43781050)
15. Crea N. et al. improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis. Obes Surg 2009;19,1084-88
16. Genco A, Bruni T, Doldi SB, et al. Bioenterics Intragastric Balloon: the Italian Experience with 2515 patients. Obes Surg. 2005;15:1161-4. (Pubitemid 41390215)
17. Suter M, Giusti V, Worreth M et al. Laparoscopic gastric banding: a prospective, randomized study comparing the LAPBAND and the SAGB: Early results. Ann Surg 2005; 241(1):55-62 (Pubitemid 40040992)
18. Shekelle PG, Morton SC, Maglione M et al. Pharmacological and surgical treatment of obesity. Evid Rep Technol Assess 2004;103(103):1-6
19. Dixon JB, O'Brien PE. Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Homeostatic model assessment. Diabet Med 2003;20(2):127-130
20. Khaitan L, Van Sickle K, Gonzalez R et al. Laparoscopic revision of bariatric procedures: is it feasible? Am Surg 2005; 71:6-10.